PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.83%
Net income growth under 50% of CRK's 132.21%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
74.82%
D&A growth well above CRK's 134.69%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-265.96%
Negative yoy deferred tax while CRK stands at 125.94%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-21.74%
Negative yoy SBC while CRK is 15.18%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-233.33%
Both reduce yoy usage, with CRK at -134.69%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-221.70%
Both yoy AR lines negative, with CRK at -134.69%. Martin Whitman would suspect an overall sector lean approach or softer demand.
343.06%
Inventory growth well above CRK's 184.10%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
101.74%
A yoy AP increase while CRK is negative at -159.92%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-233.33%
Negative yoy usage while CRK is 134.69%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-30.77%
Both negative yoy, with CRK at -87.20%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
9.03%
Some CFO growth while CRK is negative at -78.65%. John Neff would note a short-term liquidity lead over the competitor.
-30.31%
Negative yoy CapEx while CRK is 7.46%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
98.14%
Some acquisitions while CRK is negative at -100.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-82.58%
We reduce yoy other investing while CRK is 13.98%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
71.61%
We have mild expansions while CRK is negative at -3.65%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-200.00%
We cut debt repayment yoy while CRK is 35.71%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
49.44%
Buyback growth below 50% of CRK's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.